Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Substance P and Adrenocorticotropic Hormone

Research Papers that Mention the Interaction

“ Substance P decreased the plasma levels of ACTH and corticosterone but did not increase the median eminence content of vasopressin.”
Neuroimmunomodulation  •  2003  |  View Paper
“ Substance P (0.07 mg/100 g body wt) decreased ACTH plasma levels and raised corticosterone release from steroidogenic tissue, that showed clear signs of stimulation.”
General and comparative endocrinology  •  2003  |  View Paper
“However, the possibility remains to be explored that SP may play a role in quenching, via a receptor-independent mechanism, the exceedingly high glucocorticoid responses to ACTH of rat adrenocortical cells.”
Endocrine research  •  1996  |  View Paper
“These results demonstrate for the first time that SP exerts opposite effects upon the release of ACTH and AVP in the same animal, and suggest that these actions occur at the level of the hypothalamus.”
Neuroendocrinology  •  1990  |  View Paper
“… substance P (35.6 pmol) into the superficial layers (lamina I-II) of subnucleus caudalis increased the adrenal secretion of epinephrine (+8.3 +/- 2.3 …), and heart rate (+19.4 +/- 4.9 beats/min, P less than 0.01) by 1 min, and increased the plasma concentration of adrenocorticotropin (+….”
Brain Research  •  1989  |  View Paper
“In summary, these studies demonstrate that the chronic administration of ACTH or corticosterone significantly decreases the quantity of peripherally transported SP in the sensory vagus nerve and, presumably, synthesis within the vagal sensory ganglia.”
Endocrinology  •  1987  |  View Paper
“Degradation of substance P is strongly inhibited by neurotensin, somatostatin, ACTH 1-39, and less effectively by LHRH but not by Leucine-enkephalin.”
NIDA research monograph  •  1986  |  View Paper
“The results suggest that although SRIF and SP are able to modulate the release of ACTH from the anterior pituitary gland, they do so only at a high concentration.(ABSTRACT TRUNCATED AT 250 WORDS)”
The Journal of endocrinology  •  1984  |  View Paper